United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2017_register
executive
2017-11-29
article
Prospective Grant of Exclusive Patent Commercialization License: N6, A Novel, Broad, Highly Potent HIV-Specific Antibody
Notices
D09002ee1c1740173
D09002ee1c17401b0
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
National Institutes of Health
originator
org
United States Government Agency or Subagency
The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent commercialization license to GlaxoSmithKline Intellectual Property Development Ltd (GSK) located at 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
82 FR 56623
https://www.govinfo.gov/app/details/FR-2017-11-29/2017-25745
2017-25745
fr29no17-42
4140-01-P
https://www.govinfo.gov/app/details/FR-2017-11-29/2017-25745
https://www.govinfo.gov/content/pkg/FR-2017-11-29/html/2017-25745.htm
https://www.govinfo.gov/content/pkg/FR-2017-11-29/pdf/2017-25745.pdf
2 p.
56623
56624
82 FR 56623
Prospective Grant of Exclusive Patent Commercialization License: N6, A Novel, Broad, Highly Potent HIV-Specific Antibody; Federal Register Vol. 82, Issue
NOTICE
2017-25745
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
2017-12-14
4140-01-P
2017-25745
Notice.
The National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent commercialization license to GlaxoSmithKline Intellectual Property Development Ltd (GSK) located at 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Only written comments and/or applications for a license which are received by the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases on or before December 14, 2017 will be considered.
Prospective Grants of Exclusive Patent Licenses:
N6, A Novel, Broad, Highly Potent HIV-Specific Antibody
,
chris.kornak@nih.gov
Federal Register
Vol. 82, no. 228
Office of the Federal Register, National Archives and Records Administration
2017-11-29
continuing
daily
deposited
born digital
180 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2017-11-29
P0b002ee197a22c9d
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr29no17
https://www.govinfo.gov/app/details/FR-2017-11-29
https://www.govinfo.gov/content/pkg/FR-2017-11-29/pdf/FR-2017-11-29.pdf
https://www.govinfo.gov/content/pkg/FR-2017-11-29/xml/FR-2017-11-29.xml
fdlp
56529
56701
DGPO
2017-11-29
2023-10-11
FR-2017-11-29
machine generated
eng
FR
FR-2017-11-29
82
228